Ticker brief
BCAX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
3
crowd 14d
+0.60
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-25 · now +0.75 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Quantumup1 | C | · | 2 | +0.40 |
| @StockOptions888 | C | -1.78 | 2 | +0.80 |
| @OptionsFlowBoss | C | · | 1 | +0.65 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-25 | @OptionsFlowBoss | +0.65 | Lists unusual bullish options-volume multiples; ticker output capped at six. | · | tweet ↗ |
| 2026-08-25 | @StockOptions888 | +0.65 | Bullishly compares BCAX's potential setup to MRNA. | · | tweet ↗ |
| 2026-08-25 | @StockOptions888 | +0.95 | High-confidence BCAX 30 call entry for September 18 at a 0.45 average. — Explicit high-conviction call entry with strike, expiry and premium. | · | tweet ↗ |
| 2026-08-21 | @Quantumup1 | +0.40 | Citizens reiterated BCAX at Market Outperform with a $31 target after Q2 results | · | tweet ↗ |
| 2026-08-19 | @Quantumup1 | +0.40 | BMO initiated Bicara Therapeutics at Outperform with a $35 target. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.